Editorial Policies

Focus and Scope

Journal of Global Pharma Technology aims to publish research articles that explore the topic from a broad array of academic disciplines, methodologies, and perspectives. The Editors particularly encourage submissions of research that discuss current changes and interactions within the 'knowledge triangle' of research, innovation and higher education. The Editors also welcome suggestions for special issues on particular topics as well as contributions in the form of book reviews.
Journal of Global Pharma Technology aims to reach that researchers, research scholars, academicians, industrialists etc. would make use of this journal publication for the development in the field of Pharmaceutical science and advanced technology related to Pharmacy profession.
Journal of Global Pharma Technology publishes original research work that contributes significantly to the scientific knowledge in pharmacy and pharmaceutical sciences- Pharmaceutics, Novel Drug Delivery, Pharmaceutical Technology, Cosmeticology, Biopharmaceutics and Pharmacokinetics, Pharmacognosy, Natural Product Research, Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmaceutical Analysis, Pharmacology, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics, Biotechnology and Applied Computer Technology etc.


Section Policies


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

Peer Review Process
All the manuscripts submitted to Journal of Global Pharma Technology will be subjected to double-blind peer review process;
•The manuscript will be reviewed by two suitable experts in the respective subject area. The reports of both the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
•Editor-In-Chief will make the final decision, based on the reviewer’s comments.
•Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
•Associate editor and review editors provide the administrative support to maintain the integrity of peer review process.
•In case, the authors challenge the editor's negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
•Review Period: The time taken for Review is 20-25 days.


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.



The author(s) publishing their articles in this Journal is/are solely responsible for the content thereof; neither Journal of Global Pharma Technology nor its editors or publisher or anyone else involved in creating, producing or distribution assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the article, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of Journal of Global Pharma Technology.
In no event shall Journal of Global Pharma Technology be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out, or in connection with any article, Indexing of articles in any indexing database.
**Scopus is owned by Elsevier B.V. and Elsevier is solely responsible for the content selection policy of Scopus.